Patient#	Sample#	ARF6/GTP/RAB11FIP3/RAB11A:(ARF6/GTP, active),(RAB11FIP3/RAB11A, active),	Choline:(Phosphatidylcholine, active),	GM1:(ARF6/GTP, active),(fibronectin binding, active),	RAC1/GDP:(ARF6/GTP, active),(epithelial cell, active),	liver development:(ARF6/GTP, active),	myoblast fusion:(ARF6/GDP, active),	regulation of epithelial cell migration:(ARF6/GTP, active),	substrate adhesion-dependent cell spreading:(ARF6/GTP, active),	ERK1-2:(ERK1-2, protein),	KALRN:(ARF6/GDP, active),(KALRN, protein),	NME1:(NME1, protein),	PLD1-2:(ARF6/GTP, active),(PLD1-2, protein),	TIAM1:(TIAM1, protein),	ARF6/GTP/NME1/Tiam1:(ARF6/GTP, active),(NME1, active),(TIAM1, active),	ERK1-2-active:(ARF6/GTP, active),(ERK1-2, active),(ERK1-2-active, protein),	Phosphatidic acid:(PLD1-2, active),(Phosphatidylcholine, active),	PIP5K1A:(ARF6/GTP, active),(PIP5K1A, protein),(Phosphatidic acid, active),	Tumor Cell Invasion:(ERK1-2-active, active),	regulation of calcium-dependent cell-cell adhesion:(ARF6/GTP/NME1/Tiam1, active),	regulation of axonogenesis:(PIP5K1A, active),	ruffle organization:(PIP5K1A, active),	PLAUR:(PLAUR, protein),	ARF1/GTP	GDP	GTP:(GDP, active),(RhoA/GTP, active),	RhoA/GDP:(ARF6/GTP, active),(GDP, active),(RhoA/GTP, active),	PAK1:(ARF6/GTP, active),(ARF6/GTP/NME1/Tiam1, active),(GM1, active),(GTP, active),(KALRN, active),(PLAUR, active),(RAC1/GDP, active),	actin filament bundle formation:(RhoA/GDP, active),	cortical actin cytoskeleton organization:(ARF6/GTP, active),(PAK1, active),	lamellipodium assembly:(PAK1, active),	tube morphogenesis:(PAK1, active),	
